Back to results
US 2023/0405082 A1Published application
Methods for preventing and treating intra-abdominal candidiasis
AssigneeCidara Therapeutics, Inc.
InventorsKenneth BARTIZAL, Paul Daruwala, Voon Ong, Taylor Sandison
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of identifying an individual having or at risk of developing intra-abdominal candidiasis (IAC) and treating, mitigating, or preventing IAC in the individual by administering a pharmaceutical composition including CD101, in salt or neutral form, in an amount sufficient to effectively treat or prevent IAC.
Claims12
A method of treating an individual having intra-abdominal candidiasis (IAC), comprising:
- (i) identifying the individual as having IAC or suspected as having IAC;
- and
- (ii) administering to the individual a pharmaceutical composition comprising CD101 in salt or neutral form, wherein said composition is sufficient to treat the IAC.
A method of preventing IAC in an individual at risk thereof, comprising:
- (i) identifying the individual as being at risk of developing IAC;
- and
- (ii) administering to the individual a pharmaceutical composition comprising CD101 in salt or neutral form, wherein said composition is sufficient to prevent the development of IAC.
Dependencies are inferred from the claim text.